| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.082 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.3 |